Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00377078|
Recruitment Status : Unknown
Verified September 2006 by Johns Hopkins University.
Recruitment status was: Recruiting
First Posted : September 15, 2006
Last Update Posted : September 15, 2006
|Condition or disease||Intervention/treatment||Phase|
|Clostridium Difficile||Drug: recombinant human lactoferrin||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||30 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes to Manage Post-Antibiotic Colonization and Infection With Clostridium Difficile|
|Study Start Date :||October 2005|
|Study Completion Date :||October 2007|
- Subjects receive 3 grams of lactoferrin in a flush solution for the automated enteric feeding system.
- Dosing will begin with antibiotic dosing
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00377078
|Contact: William B Greenough, III, MDfirstname.lastname@example.org|
|United States, Maryland|
|Johns Hopkins Bayview Medical Center||Recruiting|
|Baltimore, Maryland, United States, 21224|
|Contact: William B Greenough, III, M.D. 410-550-0782 email@example.com|
|Principal Investigator:||William B Greenough, III, MD||Johns Hopkins University|
|Study Director:||Delia Bethell, Ph.D.||Ventria Bioscience|
|Study Chair:||Delia Bethell, Ph.D.||Ventria Bioscience|